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Background: Heat shock protein 90 (HSP90) is a molecular chaperone, and binding of HSP90 to endothelial nitric oxide (eNOS) enhances 
the activation of eNOS. We reported that thermal therapy, namely Waon therapy, up regulated eNOS protein and augmented ischemia-induced 
angiogenesis in a mouse model of hindlimb ischemia and improved limb ischemia in patient with peripheral artery disease. In order to investigate 
the underlying mechanism of Waon therapy for angiogenesis, we examined whether this thermal therapy up regulates the HSP90 involving Akt-eNOS 
pathway. 
Methods: Unilateral hindlimb ischemia was induced in apolipoprotein E-deficient mice, which were divided into control and Waon therapy 
groups. The latter mice were placed in a far-infrared ray dry sauna at 41°C for 15 min and then at 34°C for 20 min, once daily for 5 weeks. Serial 
assessment of hindlimb blood flow was performed with laser Doppler perfusion imaging in both groups. Endothelial cells of ischemic hindlimbs were 
stained with a rat monoclonal antibody against mouse CD31 and counted to measure the capillary densities. Western blotting was performed using 
antibodies for Akt, phosphorylated Akt (p-Akt), eNOS, phosphorylated eNOS (p-eNOS) and HSP90. 
Results: The ischemic limb/normal side blood perfusion ratio in the Waon therapy group was significantly increased beyond that in controls. 
Significant greater capillary density was seen in Waon therapy group compared to control group. Western blotting showed Waon therapy markedly 
up-regulated HSP90, p-Akt, eNOS, and p-eNOS in ischemic hindlimb. However, Akt was not up-regulated by Waon therapy. To support the result of 
Western blot analysis on HSP90, and to provide further information about its localization, immunohistochemical staining was performed on strip 
preparation of hindlimb. Immunohistochemistry showed that HSP90 protein was up-regulated mainly at the membrane of the skeletal muscle cells in 
Waon therapy group. 
Conclusion: Waon therapy up-regulated HSP90, which contributed to the phosphorylation of Akt and eNOS, and resulted in angiogenesis. This is 
the first report to identify the interaction between HSP90 and Akt-eNOS pathway in ischemic hindlimb.
